These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8984352

  • 1. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ, Polman CH.
    Ned Tijdschr Geneeskd; 1996 Nov 02; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug 02; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract] [Full Text] [Related]

  • 4. New treatments for multiple sclerosis.
    Hutchinson M.
    Ir Med J; 1996 Aug 02; 89(2):44. PubMed ID: 8682623
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M, Hommes OR, Hughes RA, Paty DW, Abdul-Ahad AK.
    Mult Scler; 1995 Aug 02; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon beta in the treatment of multiple sclerosis--closing remarks.
    Kappos L.
    Mult Scler; 1995 Aug 02; 1 Suppl 1():S64-6. PubMed ID: 9345403
    [No Abstract] [Full Text] [Related]

  • 9. [Interferon therapy of multiple sclerosis].
    Jensen D.
    Tidsskr Nor Laegeforen; 1999 Sep 10; 119(21):3142-5. PubMed ID: 10522481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biogen wins Euro MS approval, but loses patents.
    Brower V.
    Nat Biotechnol; 1997 May 10; 15(5):410. PubMed ID: 9131611
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of multiple sclerosis with interferon beta 1b.
    Dhib-Jalbut S, McFarland HF.
    Baillieres Clin Neurol; 1997 Oct 10; 6(3):467-80. PubMed ID: 10101584
    [Abstract] [Full Text] [Related]

  • 13. Issues in pharmaceutical lotteries: the case of interferon beta-1b.
    Manocchia M, Lasagna L.
    Clin Pharmacol Ther; 1997 Sep 10; 62(3):241-7. PubMed ID: 9333099
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Interferon beta-1b. New therapy for patients with secondary progressive multiple sclerosis].
    Nervenarzt; 1999 May 10; 70(5 Suppl):1-12. PubMed ID: 10368803
    [No Abstract] [Full Text] [Related]

  • 16. Early treatment.
    Comi G.
    Neurol Sci; 2006 Mar 10; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.